Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed May 9, 2023 · 10-Q · 39 days after period end · 0000950170-23-019680
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Net Income | -$8.99M | -$7.57M | -$8.00M | -$3.32M |
| EPS Diluted | -$0.50 | -$0.80 | -$1.30 | -$2.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Mar 31, 2023 · filed May 9, 2023 · 39 d after period end
